Abstract |
|
Authors | C Doehn, A S Merseburger, D Jocham, M A Kuczyk |
Journal | Der Urologe. Ausg. A
(Urologe A)
Vol. 46
Issue 10
Pg. 1371-2, 1374, 1376-8
(Oct 2007)
ISSN: 0340-2592 [Print] Germany |
Vernacular Title | Gibt es eine Indikation zur neoadjuvanten oder adjuvanten Systemtherapie beim Nierenzellkarzinom? |
PMID | 17805507
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Cancer Vaccines
- Interferon-alpha
- Interleukin-2
- Fluorouracil
|
Topics |
- Antineoplastic Agents
(adverse effects, therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Cancer Vaccines
(administration & dosage, adverse effects)
- Carcinoma, Renal Cell
(drug therapy, mortality, pathology, surgery)
- Chemotherapy, Adjuvant
- Clinical Trials, Phase III as Topic
- Combined Modality Therapy
- Disease-Free Survival
- Fluorouracil
(administration & dosage, adverse effects)
- Humans
- Interferon-alpha
(administration & dosage, adverse effects)
- Interleukin-2
(administration & dosage, adverse effects)
- Kidney Neoplasms
(drug therapy, mortality, pathology, surgery)
- Neoadjuvant Therapy
- Neoplasm Staging
- Nephrectomy
- Survival Rate
|